Levi & Korsinsky announces it has commenced an investigation of Revance Therapeutics Inc (NASDAQ: RVNC) concerning possible breaches of fiduciary duty.
To receive more information, please fill out the form.
Enter Your Details Below
We use cookies to ensure that we give you the best experience on our website. By using our website, you agree to the use of cookies.OkPrivacy policy